Douglas A. Arenberg

Personal Home Page

http://www2.med.umich.edu/departments/pulmonary/index.cfm?fuseaction=pulmonary.facultyBio&individual_id=35460&um_department=Internal Medicine

Articles in Scholarly Journals [Incomplete List]

  1. The predictive role of plasma TGF-ß1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer
    Lung Cancer, vol. 59, no. 2, pp. 232–239, 2008
  2. Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
    International Journal of Radiation Oncology*Biology*Physics, vol. 65, no. 4, pp. 1075–1086, 2006
  3. Journal of Proteome Research, vol. 5, no. 5, pp. 1143–1154, 2006
  4. Diversity of the Angiogenic Phenotype in Non-Small Cell Lung Cancer
    American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 3, pp. 343–350, 2006
  5. The Importance of Clinical Registries for Pulmonary Epithelioid Hemangioendothelioma
    Chest, vol. 127, no. 5, pp. 1870–1871, 2005
  6. PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-Small Cell Lung Cancer
    Neoplasia, vol. 7, no. 3, pp. 294–301, 2005
  7. The Effect of Tetrathiomolybdate on Cytokine Expression, Angiogenesis, and Tumor Growth in Squamous Cell Carcinoma of the Head and Neck
    Archives of Otolaryngology - Head and Neck Surgery, vol. 131, no. 3, pp. 204–211, 2005
  8. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma
    Cancer, vol. 101, no. 12, pp. 2779–2787, 2004
  9. Peroxisome proliferator-activated receptor-? activation inhibits tumor progression in non-small-cell lung cancer
    Oncogene, vol. 23, no. 1, Article ID 1206885, 8 pages, 2004
  10. Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model
    Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 6, pp. 1130–1137, 2004
  11. Pulmonary Epithelioid Hemangioendothelioma: An Unusual Case and a Review of the Literature
    Chest, vol. 125, no. 2, pp. 789–793, 2004
  12. In Search of the Holy Grail: Lung Cancer Biomarkers
    Chest, vol. 126, no. 2, pp. 325–326, 2004
  13. Integrin  4 1 Regulates Migration across Basement Membranes by Lung Fibroblasts: A Role for Phosphatase and Tensin Homologue Deleted on Chromosome 10
    American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 4, pp. 436–442, 2003
  14. Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
    Current Medicinal Chemistry -Anti-Cancer Agents, vol. 2, no. 3, pp. 403–417, 2002
  15. Overexpression of CXC Chemokines by an Adrenocortical Carcinoma: A Novel Clinical Syndrome
    Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 8, pp. 3968–3974, 2001
  16. Improved survival in tumor-bearing SCID mice treated with interferon-γ-inducible protein 10 (IP-10/CXCL10)
    Cancer Immunology, Immunotherapy, vol. 50, no. 10, pp. 533–538, 2001
  17. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model
    Cancer Immunology, Immunotherapy, vol. 49, no. 11, pp. 587–592, 2001
  18. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines
    Cancer Immunology, Immunotherapy, vol. 49, no. 2, pp. 63–70, 2000
  19. The CXC Chemokine, Monokine Induced by Interferon-gamma, Inhibits Non-Small Cell Lung Carcinoma Tumor Growth and Metastasis
    Human Gene Therapy, vol. 11, no. 2, pp. 247–261, 2000
  20. Angiogenesis (incorporating Angiogenesis Research), vol. 2, no. 2, pp. 123–134, 1998
  21. The Role of CXC Chemokines in the Regulation of Angiogenesis in Association with Lung Cancer
    Trends in Cardiovascular Medicine, vol. 8, no. 2, pp. 51–58, 1998
  22. Tumor angiogenesis is regulated by CXC chemokines1, 2
    Journal of Laboratory and Clinical Medicine, vol. 132, no. 2, pp. 97–103, 1998
  23. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
    Journal of Clinical Investigation, vol. 102, no. 3, pp. 465–472, 1998
  24. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
    Journal of Experimental Medicine, vol. 184, no. 3, pp. 981–992, 1996
  25. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
    Journal of Clinical Investigation, vol. 97, no. 12, pp. 2792–2802, 1996
  26. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
    Journal of Biological Chemistry, vol. 270, no. 45, pp. 27348–27357, 1995
  27. Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of Angiogenesis
    Biochemical and Biophysical Research Communications, vol. 210, no. 1, pp. 51–57, 1995
  28. Macrophage Inflammatory Protein-1a Expression in Vivo and in Vitro: The Role of Lipoteichoic Acid
    Clinical Immunology and Immunopathology, vol. 74, no. 1, pp. 77–83, 1995
  29. Regulation of Monocyte-Derived Interleukin 1 Receptor Antagonist by Cisplatinum
    Cytokine, vol. 7, no. 1, pp. 89–96, 1995